N
ABBV icon

Nuveen’s AbbVie ABBV Stock Holding History

Nuveen’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-43,200
Closed -$5K – 3316
2021
Q3 		$5K Buy
+43,200
New +$4.94M ﹤0.01% 3346
2021
Q2 		– Sell
-49,500
Closed -$5K – 3349
2021
Q1 		$5K Buy
+49,500
New +$5.29M ﹤0.01% 3323
2020
Q2 		– Sell
-51,100
Closed -$4K – 3266
2020
Q1 		$4K Buy
+51,100
New +$4.35M ﹤0.01% 3158

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nuveen's ABBV Position: Q1 2026 in Review

Nuveen increased its AbbVie (ABBV) stake by 29% in Q1 2026, buying an estimated $556M and bringing the position to 11,115,159 shares worth $2.42B. The position accounts for 0.65% of the portfolio, ranked #19.

Nuveen first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.62B in Q1 2022. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Nuveen held 11,115,159 shares of AbbVie worth $2.42B as of Q1 2026.
  • Nuveen bought 2,507,133 AbbVie shares in Q1 2026, an estimated $556M.
  • AbbVie made up 0.65% of Nuveen's portfolio in Q1 2026, its #19 holding.
  • Nuveen first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Nuveen's AbbVie position peaked at $2.62B in Q1 2022.
  • 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.